SCHEMBL6355229

SCHEMBL6355229

Cc1cc(N)c2nc(C)cn2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 5/20 0.37
ALDH1A1 P00352 4/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PIK3R1 P27986 1/20 0.35
PIK3CA P42336 1/20 0.35
NOS3 P29474 1/20 0.34
NOS1 P29475 1/20 0.34
NOS2 P35228 1/20 0.34
KDM4E B2RXH2 2/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
APP P05067 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
TP53 P04637 1/20 0.32
CYP3A4 P08684 1/20 0.32
THRB P10828 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4891536 0.81 RXFP1 (0.41) ALDH1A1HPGDHSD17B10PIK3R1PIK3CA
SCHEMBL12920733 0.79 GRM5 (0.39) GRM5ALDH1A1HPGDHSD17B10PIK3R1
SCHEMBL6850328 0.77 GRM5 (0.44) GRM5ALDH1A1KDM4ELMNAMAPT
SCHEMBL31286459 0.77 PIK3R1 (0.32) ALDH1A1HPGDHSD17B10PIK3R1PIK3CA
SCHEMBL23571405 0.76 GRM5 (0.37) GRM5ALDH1A1PIK3R1PIK3CAKDM4E
SCHEMBL24163731 0.76 GRM5 (0.42) GRM5ALDH1A1PIK3R1PIK3CAKDM4E
SCHEMBL6217320 0.75 GRM5 (0.43) GRM5ALDH1A1HSD17B10KDM4ELMNA
SCHEMBL4654965 0.75 RXFP1 (0.38) GRM5ALDH1A1HPGDHSD17B10KDM4E
Bromide SCHEMBL5306710 0.74 RXFP1 (0.37) GRM5ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL25096400 0.73 KDM4E (0.38) GRM5ALDH1A1HPGDHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050154007-A1 New compounds AMIN KOSRAT (SE) 2005-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050154007-A1 New compounds SLC10A2, GIPR, FABP6 GRM5 975/4885ALDH1A1 1838/4885HPGD 156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.